These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9990685)

  • 1. Skeletal metastases from breast cancer: imaging with nuclear medicine.
    Cook GJ; Fogelman I
    Semin Nucl Med; 1999 Jan; 29(1):69-79. PubMed ID: 9990685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Potential of Radiolabeled Bisphosphonates in SPECT and PET for Bone Imaging.
    Ashhar Z; Ahmad Fadzil MF; Hassan H; Othman MF; Md Hassan MB; Chun Vui VY; Guat Choo C; Yusof NA
    Curr Med Imaging; 2024; 20(1):e15734056270935. PubMed ID: 38874043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
    Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
    Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear Medicine Imaging Techniques for Detection of Skeletal Metastases in Breast Cancer.
    Iagaru A; Minamimoto R
    PET Clin; 2018 Jul; 13(3):383-393. PubMed ID: 30100077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTc-MDP Bone Scan and 18F-FDG PET/CT Imaging of Multiple Extraskeletal Osteosarcomas.
    Sun ZK; Shen CT; Qiu ZL; Luo QY
    Clin Nucl Med; 2018 Nov; 43(11):e412-e413. PubMed ID: 30106862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of Bone Metastases in Breast Cancer.
    Cook GJR
    Semin Nucl Med; 2022 Sep; 52(5):531-541. PubMed ID: 35236615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone Metastases.
    Cook GJR; Thorpe MP
    Cancer J; 2024 May-Jun 01; 30(3):202-209. PubMed ID: 38753755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should de-escalation of bone-targeting agents be standard of care for patients with bone metastases from breast cancer? A systematic review and meta-analysis.
    Liu C; Wang L; Zhuang J; Liu L; Zhou C; Feng F; Sun C
    Ann Oncol; 2018 May; 29(5):1329-1330. PubMed ID: 29788163
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypermetabolic activity of soft tissues and bones in an HIV patient.
    Zaghdoudi A; Moretto F
    QJM; 2023 Jul; 116(7):525. PubMed ID: 36752532
    [No Abstract]   [Full Text] [Related]  

  • 11.
    Cancer Biother Radiopharm; 2022 Mar; 37(2):159. PubMed ID: 35294306
    [No Abstract]   [Full Text] [Related]  

  • 12. Estrogen Receptor-targeted PET Imaging for Breast Cancer.
    Zhou W; Franc BL; DeMartini WB; Rosen EL
    Radiology; 2024 Aug; 312(2):e240315. PubMed ID: 39136565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal Imaging-Based Potential Visualization of the Tumor Microenvironment in Bone Metastasis.
    Moon JB; Yoo SW; Lee C; Kim DY; Pyo A; Kwon SY
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semiquantitative assessment of osteoblastic, osteolytic, and mixed lytic-sclerotic bone lesions on fluorodeoxyglucose positron emission tomography/computed tomography and bone scintigraphy.
    Gurkan G; Sarikaya I; Sarikaya A
    World J Nucl Med; 2019; 18(2):132-136. PubMed ID: 31040743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The EANM practice guidelines for bone scintigraphy.
    Van den Wyngaert T; Strobel K; Kampen WU; Kuwert T; van der Bruggen W; Mohan HK; Gnanasegaran G; Delgado-Bolton R; Weber WA; Beheshti M; Langsteger W; Giammarile F; Mottaghy FM; Paycha F;
    Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1723-38. PubMed ID: 27262701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of general nuclear medicine in breast cancer.
    Greene LR; Wilkinson D
    J Med Radiat Sci; 2015 Mar; 62(1):54-65. PubMed ID: 26229668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current imaging techniques in rheumatology: MRI, scintigraphy and PET.
    Sudoł-Szopińska I; Cwikła JB
    Pol J Radiol; 2013 Jul; 78(3):48-56. PubMed ID: 24115960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between bone scintigraphy and tumor markers in patients with breast carcinoma.
    Begić A; Kucukalić-Selimović E; Obralić N; Durić O; Lacević N; Skopljak A
    Bosn J Basic Med Sci; 2006 Feb; 6(1):75-7. PubMed ID: 16533185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of bone scintigraphy and tumor marker-Ca 15-3 in detection of bone metastases in patients with breast cancer.
    Begić A; Kucukalić-Selimović E; Obralić N; Durić O; Lacević N; Begović S; Dzubur-Aganović M
    Bosn J Basic Med Sci; 2005 Feb; 5(1):23-6. PubMed ID: 15771599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantages and limitations of FDG PET in the follow-up of breast cancer.
    Lind P; Igerc I; Beyer T; Reinprecht P; Hausegger K
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S125-34. PubMed ID: 15085295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.